Industry / United States
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Evolving Role Of Trade As A Weapon Against Counterfeits
April 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
The usual bold plans for using trade to leverage improved intellectual property (IP) provisions were contained within the Office of the US Trade Representative (USTR)'s 2008 National Trade Estimate (NTE) report, which was delivered to Congress in March.